RE:RE:It's not about Tweed vs. Bedrocan Vs. Mettrum vs. also rans-It's axiomatic that investors don't like uncertainty. No surprise then that the injunction has tempered the initial enthusiasm for the MMPR market. The path to profitability has been prolonged. Even the best MMPR companies (TWD certainly being an exemplar of these) have drifted lower over most longish time periods that you could chart them. Vets, military personal, RCMP, university students, (anyone who's MMJ meds are not paid by them personally) and others will continue to gravitate toward the most legit medical providers. That there is plenty of silver lining here is unquestionable. But that injunction is quite an annoying cloud during a time when these companies are struggling to become profitable. I'm long this market - but not nearly as long as I once was. I'm contemplating going longer again, but with tepid enthusiasm until there is less uncertainty and/or lower losses. That sums up my opinion best. Thanks for asking GG. -GLTA